Resolution of severe diarrhoea and return to work in a patient converted from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®)

被引：0
|
作者：
Lord H. [1 ,2 ]
机构：
[1] University of Montréal, Montréal, Que.
[2] Maisonneuve Rosemont, University of Montréal, Montréal, Que. HIT 2M4
来源：
Drugs | 2006年 / 66卷 / Suppl 2期
关键词：
Sirolimus; Risedronate; Mycophenolate Mofetil; Graft Function; Darbepoetin Alfa;
D O I：
10.2165/00003495-200666002-00004
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
下载
收藏
页码：11 / 13
页数：2
相关论文
共 50 条
  • [31] Omeprazole Impairs the Absorption of Mycophenolate Mofetil But Not of Enteric-Coated Mycophenolate Sodium in Healthy Volunteers
    Kees, M. G.
    Steinke, T.
    Moritz, S.
    Rupprecht, K.
    Paulus, E. M.
    Kees, F.
    Bucher, M.
    Faerber, L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (08): : 1265 - 1272
  • [32] Comparison of enteric-coated mycophenolate sodium with mycophenolate mofetil in living renal allograft transplantation
    Minz, M.
    Sharma, A.
    Heer, M.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (07) : 2041 - 2043
  • [33] Drugs supplement -: Clinical experience with enteric-coated mycophenolate sodium (myfortic®) -: Foreword
    Bloom, Roy D.
    Rostaing, Lionel
    DRUGS, 2006, 66
  • [34] Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
    Liao, Yu-Wan
    Hung, Wei-Ting
    Chen, Yi-Ming
    Hsu, Chiann-Yi
    Lin, Ching-Heng
    Hsieh, Tsu-Yi
    Chen, Hsin-Hua
    Hsieh, Chia-Wei
    Lin, Ching-Tsai
    Lai, Kuo-Lung
    Tang, Kuo-Tung
    Tseng, Chih-Wei
    Chen, Yi-Hsing
    Huang, Wen-Nan
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (02) : E633 - E637
  • [35] Improvement in Social Functioning in Kidney Transplant Patients after Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®): Three Case Studies
    Tariq Shah
    Drugs, 2006, 66 (Suppl 2) : 15 - 17
  • [36] Enteric-coated Mycophenolate Sodium (myfortic®): An Overview of Current and Future Use in Transplantation
    Bruce Kaplan
    Drugs, 2006, 66 (Suppl 2) : 1 - 8
  • [37] Enteric-coated mycophenolate sodium (myfortic®):: An overview of current and future use in transplantation
    Kaplan, Bruce
    DRUGS, 2006, 66 : 1 - 8
  • [38] Enteric-coated mycophenolate sodium: Safe conversion from mycophenolate mofetil in maintenance renal transplant recipients
    Budde, K
    Glander, P
    Diekmann, F
    Dragun, D
    Waiser, J
    Fritsche, L
    Neumayer, HH
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (02) : 524S - 527S
  • [39] Switching From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Liver Transplant Patients With Gastrointestinal Complications
    Barrera-Pulido, L.
    Alamo-Martinez, J. M.
    Marin-Gomez, L. M.
    Suarez-Artacho, G.
    Bernal-Bellido, C.
    Dominguez-Usero, D.
    Tallon-Aguilar, L.
    Pareja-Ciuro, F.
    Sousa-Martin, J. M.
    Garcia-Gonzalez, I.
    Gomez-Bravo, M. A.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (06) : 2192 - 2194
  • [40] Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
    Jia, Yichen
    Wang, Rulin
    Li, Long
    Zhang, Ying
    Li, Jiawei
    Wang, Jina
    Wang, Xuanchuan
    Qi, Guisheng
    Rong, Ruiming
    Xu, Ming
    Zhu, Tongyu
    BMC PHARMACOLOGY & TOXICOLOGY, 2018, 19
12345